At PromiseCare Medical Group in Hemet, California, radiofrequency ablation (RFA) is a minimally invasive treatment option that uses heat to destroy cancer cells.
RFA procedures are typically done on an outpatient basis, lasting between 30 minutes to 3 hours, and require only local anesthesia.
By precisely targeting cancer cells, RFA reduces damage to surrounding healthy tissue, minimizing scarring and recovery time.
According to data from PromiseCare Medical Group, local recurrence rates can be as low as 9% in some cases, making RFA a promising treatment option for cancer patients.
Overview
Radiofrequency ablation (RFA) is a minimally invasive procedure that has emerged as a promising treatment option in cancer care. This technique uses high-frequency electrical energy to generate heat, effectively killing cancer cells in localized tumors. RFA is particularly useful for treating lung tumors and other forms of cancer.
RFA targets and eliminates cancer cells as a thermal ablative procedure while minimizing damage to surrounding healthy tissue. The process is typically performed on an outpatient basis, and most procedures take 30 minutes to 3 hours to complete.
After the procedure, follow-up imaging is necessary to assess the tumor’s response to treatment. Regular check-ins are usually scheduled every 3 to 4 months to monitor for any signs of cancer recurrence.
RFA provides a proactive method for cancer treatment, offering a practical and empowering minimally invasive choice. For those considering this option, RFA can instill hope and facilitate healing in their cancer journey.
Types
Radiofrequency ablation (RFA) is not a universal remedy in cancer treatment. Instead, it belongs to a comprehensive group of ablative techniques designed to precisely target cancer cells with minimal invasiveness. Various effective methods accompany RFA, each offering distinct advantages and strategies for tumor elimination.
Microwave Ablation, for example, utilizes electromagnetic energy to effectively heat and destroy tumors, presenting an alternative to RFA. Conversely, Cryoablation employs freezing tumor cells with liquid nitrogen or argon gas, offering a method of tumor elimination that spares nearby tissues from extensive harm.
Each ablation method targets tumors based on specific characteristics, such as size and location; this guarantees personalized treatment options for patients, particularly regarding the ablation of lung tumors. Local ablative therapies, like RFA, can be performed using a percutaneous approach, where a thin probe is inserted through the skin or bronchoscopy for lung tumors. This versatility makes RFA and its counterparts invaluable tools in the fight against cancer, offering patients a range of effective and minimally invasive treatment options.
Ablation techniques like RFA effectively target tumors in various parts of the body. The choice of treatment often depends on the specific characteristics of the cancer. For instance, some tumors may be more suitable for Microwave Ablation or Cryoablation due to their location or size. Understanding the options available can help patients make informed decisions about their treatment plans.
The use of ablation techniques has become increasingly popular in recent years. These techniques offer a range of benefits, including minimal scarring, reduced recovery time, and fewer complications compared to traditional surgical methods. These benefits make ablation techniques an attractive option for patients seeking effective and minimally invasive treatments for cancer.
Why it’s done
Radiofrequency ablation (RFA) is often recommended as a treatment option for tumors in tricky locations, making surgery too risky, or for patients with health conditions that make traditional surgery a concern.
It’s particularly effective for tumors smaller than 5 cm and is commonly used to treat primary liver cancer, liver metastases, and select cases of lung and kidney cancer, including non-small-cell lung cancer (NSCLC).
RFA may be suggested for patients who aren’t good candidates for surgery or those with multiple tumors that complicate traditional surgery.
The procedure can help alleviate symptoms like pain or discomfort caused by localized cancers.
Performed under local anesthesia, RFA uses heat to destroy cancer cells, offering a less invasive treatment option than surgery.
While RFA may not be a cure, it can improve quality of life by targeting the tumor directly, managing symptoms, and potentially slowing cancer growth, making it a valuable treatment option.
Who it’s for
Someone facing a cancer diagnosis wants to know they’ve options – and for many, radiofrequency ablation (RFA) is a viable treatment choice.
The suitability of RFA depends on the specifics of the condition. Patients with a localized tumor smaller than 5 cm may be candidates for RFA, particularly those with primary liver cancer, lung metastases, and kidney cancer.
RFA is also an alternative for individuals who aren’t candidates for surgical options due to health issues or the complexity of the surgical site.
Additionally, patients with precancerous conditions, such as Barrett’s esophagus or those facing recurrent tumors that require multiple treatments, may benefit from RFA.
This minimally invasive approach can help avoid side effects associated with more aggressive cancer treatments. RFA is typically performed in specialized centers, which may require travel.
Patients should consult their healthcare provider to decide whether RFA is an appropriate treatment option.
Risks
Beneath the promise of radiofrequency ablation‘s minimally invasive approach lies a landscape of potential risks, which must be carefully navigated. When considering this treatment, it’s essential to weigh the benefits against the possible complications that can arise.
Infection is a rare but potential risk, requiring close monitoring and prompt treatment if it occurs. Flu-like symptoms, including fever and discomfort, can last several days after the procedure.
More serious complications can also occur, including thermal injuries to surrounding tissues and bleeding. In some cases, such as lung cancer treatment, pneumothorax – a collapsed lung – can happen. While most instances are minor, being aware of this risk is vital.
Additionally, some patients may experience blood in their urine after kidney RFA, which typically resolves independently but should be reported to a healthcare provider. Understanding the potential risks and complications is crucial for making an informed decision about treatment and navigating the challenges that may arise during and after radiofrequency ablation.
How you prepare
Preparation is crucial for a smooth and successful radiofrequency ablation procedure. Typically, a pre-assessment appointment occurs about a week before the procedure. During this appointment, health, allergies, and medications are discussed, and any concerns or questions about the treatment are addressed.
Medications, including blood-thinning medications, are reviewed, and any necessary adjustments are made. Blood tests are used to evaluate health and organ function and assess suitability for the procedure. Imaging tests, such as CT scans, are also conducted to locate the tumor precisely and guide the insertion of the probe.
On the day of the procedure, fasting for several hours is required to minimize complications and enhance safety; this means no food or drink, not even water, to ensure an empty stomach and reduce the risk of complications.
What you can expect
A radiofrequency ablation procedure unfolds with precision, guided by a medical team that has carefully prepared the patient for the treatment. As the treatment begins, the patient feels the gentle pressure of the probe being inserted, guided by precise imaging from a CT or ultrasound machine.
The heat generated by the RFA courses through the body, precisely targeting cancer cells. The procedure can last anywhere from 30 minutes to 3 hours.
After the treatment, the anesthesia wears off, and the medical team monitors the patient for side effects, watching for signs of pain or fever.
The patient rests and recovers in the following days, allowing the body to heal from the treatment. Post-treatment imaging is scheduled to evaluate the procedure’s effectiveness and check for any cancer recurrence.
Normal activities can typically be resumed within a few days, but specific care instructions provided by healthcare providers should be followed, allowing time for rest and healing.
Results
Results
The focus shifts to the outcome after undergoing radiofrequency ablation (RFA). The effectiveness of RFA in eliminating cancer cells is a key concern. Research has shown that RFA achieves local recurrence rates ranging from 9% to 40% for treated tumors, with better outcomes observed in solitary tumors smaller than 3 cm.
For lung cancer, RFA has demonstrated overall survival rates of 70% to 90% for early-stage patients, making it a viable option for local control and palliation.
The type and stage of cancer also influence survival chances. Five-year overall survival rates for patients undergoing RFA vary between 18% and 30%, particularly in cases of liver and lung tumors.
These statistics provide a general idea of what to expect, but it’s essential to remember that every individual’s situation is unique. Patients who’ve undergone minimally invasive RFA procedures can take comfort in knowing that they’ve chosen a treatment with an acceptable safety profile, especially if they have co-morbidities or aren’t candidates for surgery.
Now, the focus is on how the body responds to the treatment.